查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1342081

全球藥物發現人工智能市場預測（~2030 年）

Artificial Intelligence in Drug Discovery Market Research Report Forecast to 2030
出版日期: | 出版商: Market Research Future | 英文 132 Pages | 訂單完成後即時交付

價格

預計在預測期內，全球人工智能藥物發現市場規模將以 29.83% 的複合年增長率大幅增長。 人們對人工智能在藥物發現方面的接受程度不斷提高、人工智能在藥物發現方面重大舉措的興起以及利用人工智能的新藥物發現公司的激增正在推動商業領域的發展。

區域考慮

2022年北美市場佔據最大份額。

歐洲市場佔據第二大份額。

預計 2023 年至 2030 年亞太市場將出現顯著增長。

由於慢性病和傳染病的流行，藥品需求增加，中東/非洲/拉丁美洲市場可能會發展。

本報告研究和分析了全球人工智能藥物發現市場，提供市場動態、區域和細分分析、公司概況等。

目錄

第 1 章執行摘要

第二章市場介紹

第三章研究方法

第 4 章市場動態

  • 摘要
  • 促進因素
    • 越來越多地採用人工智能進行藥物發現
    • 加大人工智能在藥物發現方面的戰略力度
    • 使用人工智能進行藥物研發的初創公司有所增加
  • 抑制因素
    • 缺乏人工智能人力資源
  • 機會
    • 新興市場

第五章市場因素分析

  • 價值鏈分析
    • 研究與開發
    • 製造業
    • 分銷、銷售
    • 售後監控
  • 波特五力分析模型
  • COVID-19 對全球藥物發現人工智能的影響
    • 對供應鏈的影響
    • 對服務需求的影響
    • 對市場進入者的影響

第 6 章全球藥物發現人工智能市場：按產品/服務劃分

  • 摘要
  • 軟件
  • 服務

第 7 章全球藥物發現人工智能市場：按分子類型劃分

  • 摘要
  • 聚合物
  • 小分子

第 8 章全球藥物發現人工智能市場：按技術劃分

  • 摘要
  • 機器學習
  • 深度學習
  • 其他

第 9 章用於藥物發現的全球人工智能市場：按適應症劃分

  • 摘要
  • 癌症免疫力
  • 神經退行性疾病
  • 心血管疾病
  • 代謝性疾病
  • 其他

第 10 章全球藥物發現人工智能市場：按應用劃分

  • 摘要
  • 目標識別
  • 候選人篩選
  • 從頭藥物設計
  • 藥物優化和再利用
  • 臨床前研究

第 11 章全球藥物發現人工智能市場：按地區劃分

  • 摘要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 亞太地區其他地區
  • 其他領域
    • 中東
    • 非洲
    • 拉丁美洲

第十二章競爭態勢

  • 摘要
  • 競爭基準測試
  • 全球藥物發現人工智能市場的主要增長戰略
  • 在全球藥物發現人工智能市場的開發數量方面處於領先地位
  • 主要進展分析
  • 主要發展和增長戰略
    • 開辦服務/公司
    • 合併/收購
    • 合作夥伴關係/附屬關係/協議

第十三章公司簡介

  • IBM
  • ALPHABET INC.
  • ATOMWISE INC.
  • DEEP GENOMICS
  • CLOUD PHARMACEUTICALS, INC.
  • MICROSOFT CORPORATION
  • INSILICO MEDICINE
  • CYCLICA
  • BENEVOLENTAI
  • EXSCIENTIA

第14章 附錄

Product Code: MRFR/Pharma/7918-CR

Market Overview

The Artificial Intelligence in Drug Discovery Market is anticipated to register a substantial CAGR of 29.83% during the forecast period. The increasing reception of simulated intelligence in drug discovery, rising key initiatives for man-made intelligence in drug discovery, and the increasing number of man-made intelligence-powered drug discovery new companies are driving business sector development.

The reception of simulated intelligence in drug discovery is rising among industries, including drug and biotechnology organizations. This is essentially owing to the way that artificial intelligence offers progressed benefits to discovering drug particles and paces up the drug discovery process. Further, artificial intelligence gives significant insights to work on the designing, optimizing, and synthesizing of drugs. There are a few factors that are increasing the reception of man-made intelligence for drug discovery. The absolute most predominant ones include the rising incidences of ongoing illnesses and accuracy medicine, owing to the emerging way to deal with the counteraction and treatment of sicknesses. Besides, a few market members are increasing the accuracy of their drug portfolios, a cycle that has been seen to exhibit an increase in the reception of man-made intelligence advancements.

Market Segmentation

Based on product and service Artificial Intelligence in Drug Discovery, is classified into software and services. Based on a molecule type the market is divided into large molecules and small molecules. The Market of Artificial Intelligence in Drug Discovery based on technology is divided into machine learning, deep learning, and others.

Based on an indication the market is classified into immuno-oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, and others. Based on an application the market is categorized into target identification, candidate screening, de novo drug designing, drug optimization and repurposing, and preclinical testing.

Regional Insights

The North American artificial intelligence in the drug discovery market represented the biggest piece of the pie in 2022. This is because of the increasing incidences of ongoing illnesses, many leading new companies, and increasing drug Research and development investments in the region.

Europe's artificial intelligence in the drug discovery market represents the second-biggest piece of the pie because of the rising pervasiveness of uncommon illnesses across Europe and increasing the demand for a simulated intelligence-driven stage for drug discovery. Moreover, Germany's market of artificial intelligence

The Asia-Pacific artificial intelligence in drug discovery market is supposed to develop at a huge offer from 2023 to 2030. This is because of the rising weight of sickness and the tremendous number of biopharmaceutical industries that are adopting computer-based intelligence abilities in the Asia-Pacific region.

The rest of the World is fragmented into the Center East, Africa, and Latin America. Artificial intelligence in the drug discovery market in the previously mentioned regions is probably going to observe development because of the increasing demand for drugs because of the rising incidences of persistent and infectious illnesses.

Major Players

Key Companies in the Artificial Intelligence in Drug Discovery Market include IBM (US), Alphabet Inc (US), Atomwise Inc (US), Deep Genomics (Canada), Cloud Pharmaceuticals, Inc (US), Microsoft corporation (US), Insilico Medicine (China), Cyclica (Canada), BenevolentAI (UK), and Exscientia (UK).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW
    • 1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA MINING
  • 3.3 SECONDARY RESEARCH
  • 3.4 PRIMARY RESEARCH
    • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
    • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING ADOPTION OF AI IN DRUG DISCOVERY
    • 4.2.2 RISING STRATEGIC INITIATIVES FOR AI IN DRUG DISCOVERY
    • 4.2.3 INCREASING NUMBER OF AI-POWERED DRUG DISCOVERY START-UPS
  • 4.3 RESTRAINTS
    • 4.3.1 SHORTAGE OF AI WORKFORCE
  • 4.4 OPPORTUNITIES
    • 4.4.1 EMERGING MARKETS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION & SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL AI IN DRUG DISCOVERY
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON SERVICE DEMAND
    • 5.3.3 IMPACT ON MARKET PLAYERS

6 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT AND SERVICE

  • 6.1 OVERVIEW
  • 6.2 SOFTWARE
  • 6.3 SERVICES

7 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE

  • 7.1 OVERVIEW
  • 7.2 LARGE MOLECULE
  • 7.3 SMALL MOLECULE

8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY

  • 8.1 OVERVIEW
  • 8.2 MACHINE LEARNING
  • 8.3 DEEP LEARNING
  • 8.4 OTHERS

9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION

  • 9.1 OVERVIEW
  • 9.2 IMMUNO-ONCOLOGY
  • 9.3 NEURODEGENERATIVE DISEASES
  • 9.4 CARDIOVASCULAR DISEASES
  • 9.5 METABOLIC DISEASES
  • 9.6 OTHERS

10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION

  • 10.1 OVERVIEW
  • 10.2 TARGET IDENTIFICATION
  • 10.3 CANDIDATE SCREENING
  • 10.4 DE NOVO DRUG DESIGNING
  • 10.5 DRUG OPTIMIZATION AND REPURPOSING
  • 10.6 PRECLINICAL TESTING

11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 US
    • 11.2.2 CANADA
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 FRANCE
    • 11.3.3 UK
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 JAPAN
    • 11.4.3 INDIA
    • 11.4.4 AUSTRALIA
    • 11.4.5 SOUTH KOREA
    • 11.4.6 REST OF ASIA-PACIFIC
  • 11.5 REST OF THE WORLD
    • 11.5.1 MIDDLE EAST
    • 11.5.2 AFRICA
    • 11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 COMPETITIVE BENCHMARKING
  • 12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
  • 12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
  • 12.5 KEY DEVELOPMENT ANALYSIS
  • 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 12.6.1 SERVICE/COMPANY LAUNCH
    • 12.6.2 MERGER/ACQUISITION
    • 12.6.3 PARTNERSHIP/COLLABORATION/AGREEMENT

13 COMPANY PROFILES

  • 13.1 IBM
    • 13.1.1 COMPANY OVERVIEW
    • 13.1.2 FINANCIAL OVERVIEW
    • 13.1.3 SOFTWARE/SERVICES OFFERED
    • 13.1.4 KEY DEVELOPMENTS
    • 13.1.5 SWOT ANALYSIS
    • 13.1.6 KEY STRATEGIES
  • 13.2 ALPHABET INC.
    • 13.2.1 COMPANY OVERVIEW
    • 13.2.2 FINANCIAL OVERVIEW
    • 13.2.3 SOFTWARE/SERVICES OFFERED
    • 13.2.4 KEY DEVELOPMENTS
    • 13.2.5 SWOT ANALYSIS
    • 13.2.6 KEY STRATEGIES
  • 13.3 ATOMWISE INC.
    • 13.3.1 COMPANY OVERVIEW
    • 13.3.2 FINANCIAL OVERVIEW
    • 13.3.3 SOFTWARE/SERVICES OFFERED
    • 13.3.4 KEY DEVELOPMENTS
    • 13.3.5 SWOT ANALYSIS
    • 13.3.6 KEY STRATEGIES
  • 13.4 DEEP GENOMICS
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 FINANCIAL OVERVIEW
    • 13.4.3 SOFTWARE/SERVICES OFFERED
    • 13.4.4 KEY DEVELOPMENTS
    • 13.4.5 KEY STRATEGIES
  • 13.5 CLOUD PHARMACEUTICALS, INC.
    • 13.5.1 COMPANY OVERVIEW
    • 13.5.2 FINANCIAL OVERVIEW
    • 13.5.3 SOFTWARE/SERVICES OFFERED
    • 13.5.4 KEY DEVELOPMENTS
    • 13.5.5 KEY STRATEGIES
  • 13.6 MICROSOFT CORPORATION
    • 13.6.1 COMPANY OVERVIEW
    • 13.6.2 FINANCIAL OVERVIEW
    • 13.6.3 SERVICES OFFERED
    • 13.6.4 KEY DEVELOPMENTS
    • 13.6.5 SWOT ANALYSIS
    • 13.6.6 KEY STRATEGIES
  • 13.7 INSILICO MEDICINE
    • 13.7.1 COMPANY OVERVIEW
    • 13.7.2 FINANCIAL OVERVIEW
    • 13.7.3 SERVICES OFFERED
    • 13.7.4 KEY DEVELOPMENTS
    • 13.7.5 KEY STRATEGIES
  • 13.8 CYCLICA
    • 13.8.1 COMPANY OVERVIEW
    • 13.8.2 FINANCIAL OVERVIEW
    • 13.8.3 SERVICES OFFERED
    • 13.8.4 KEY DEVELOPMENTS
    • 13.8.5 KEY STRATEGIES
  • 13.9 BENEVOLENTAI
    • 13.9.1 COMPANY OVERVIEW
    • 13.9.2 FINANCIAL OVERVIEW
    • 13.9.3 SERVICES OFFERED
    • 13.9.4 KEY DEVELOPMENTS
    • 13.9.5 SWOT ANALYSIS
    • 13.9.6 KEY STRATEGIES
  • 13.10 EXSCIENTIA
    • 13.10.1 COMPANY OVERVIEW
    • 13.10.2 FINANCIAL OVERVIEW
    • 13.10.3 SOFTWARES OFFERED
    • 13.10.4 KEY DEVELOPMENTS
    • 13.10.5 KEY STRATEGIES

14 APPENDIX

  • 14.1 REFERENCES
  • 14.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 3 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR PRODUCT, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 4 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR SERVICES, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 5 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 6 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR LARGE MOLECULE, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 7 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR SMALL MOLECULE, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 9 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR MACHINE LEARNING, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 10 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DEEP LEARNING, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 11 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 12 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 13 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR IMMUNO-ONCOLOGY, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 14 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR NEURODEGENERATIVE DISEASES, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 15 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 16 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR METABOLIC DISEASES, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 17 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 18 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 19 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR TARGET IDENTIFICATION, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 20 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR CANDIDATE SCREENING, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 21 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DE NOVO DRUG DESIGNING, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 22 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DRUG OPTIMIZATION AND REPURPOSING, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 23 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR PRECLINICAL TESTING, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 24 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 25 NORTH AMERICA: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
  • TABLE 26 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 27 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 28 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 29 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 30 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 31 US AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 32 US AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 33 US AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 34 US AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 35 US AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 36 CANADA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 37 CANADA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 38 CANADA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 39 CANADA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 40 CANADA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 41 EUROPE: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
  • TABLE 42 EUROPE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 43 EUROPE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 44 EUROPE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 45 EUROPE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 46 EUROPE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 47 GERMANY AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 48 GERMANY AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 49 GERMANY AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 50 GERMANY AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 51 GERMANY AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 52 FRANCE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 53 FRANCE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 54 FRANCE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 55 FRANCE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 56 FRANCE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 57 UK AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 58 UK AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 59 UK AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 60 UK AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 61 UK AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 62 ITALY AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 63 ITALY AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 64 ITALY AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 65 ITALY AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 66 ITALY AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 67 SPAIN AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 68 SPAIN AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 69 SPAIN AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 70 SPAIN AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 71 SPAIN AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 72 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 73 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 74 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 75 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 76 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 77 ASIA-PACIFIC: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2018-2030 (USD BILLION)
  • TABLE 78 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 79 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 80 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 81 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 82 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 83 CHINA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 84 CHINA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 85 CHINA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 86 CHINA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 87 CHINA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 88 JAPAN AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 89 JAPAN AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 90 JAPAN AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 91 JAPAN AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 92 JAPAN AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 93 INDIA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 94 INDIA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 95 INDIA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 96 INDIA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 97 INDIA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 98 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 99 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 100 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 101 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 102 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 103 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 104 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 105 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 106 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 107 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 108 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 109 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 110 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 111 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 112 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 113 REST OF THE WORLD: AI IN DRUG DISCOVERY MARKET, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 114 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 115 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 116 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 117 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 118 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 119 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 120 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 121 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 122 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 123 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 124 AFRICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 125 AFRICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 126 AFRICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 127 AFRICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 128 AFRICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 129 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
  • TABLE 130 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
  • TABLE 131 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
  • TABLE 132 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
  • TABLE 133 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 134 MAJOR PLAYERS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
  • TABLE 135 MOST ACTIVE PLAYER IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
  • TABLE 136 SERVICE/COMPANY LAUNCH
  • TABLE 137 MERGER/ACQUISITION
  • TABLE 138 PARTNERSHIP/COLLABORATION/AGREEMENT
  • TABLE 139 IBM: SOFTWARE/SERVICES OFFERED
  • TABLE 140 IBM: KEY DEVELOPMENTS
  • TABLE 141 ALPHABET INC.: SOFTWARE/SERVICES OFFERED
  • TABLE 142 ALPHABET INC.: KEY DEVELOPMENTS
  • TABLE 143 ATOMWISE INC.: SOFTWARE/SERVICES OFFERED
  • TABLE 144 ATOMWISE INC.: KEY DEVELOPMENTS
  • TABLE 145 DEEP GENOMICS: SOFTWARE/SERVICES OFFERED
  • TABLE 146 CLOUD PHARMACEUTICALS, INC.: SOFTWARE/SERVICES OFFERED
  • TABLE 147 CLOUD PHARMACEUTICALS, INC.: KEY DEVELOPMENTS
  • TABLE 148 MICROSOFT CORPORATION: SERVICES OFFERED
  • TABLE 149 INSILICO MEDICINE: SERVICES OFFERED
  • TABLE 150 CYCLICA: SERVICES OFFERED
  • TABLE 151 BENEVOLENTAI: SERVICES OFFERED
  • TABLE 152 EXSCIENTIA: SOFTWARES OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL AI IN DRUG DISCOVERY MARKET STRUCTURE
  • FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE AI IN DRUG DISCOVERY
  • FIGURE 4 DRIVER IMPACT ANALYSIS
  • FIGURE 5 RESTRAINT IMPACT ANALYSIS
  • FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL AI IN DRUG DISCOVERY
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL AI IN DRUG DISCOVERY
  • FIGURE 8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2022 & 2030 (USD BILLION)
  • FIGURE 9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2022 & 2030 (USD BILLION)
  • FIGURE 10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2022 & 2030 (USD BILLION)
  • FIGURE 11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2022 & 2030 (USD BILLION)
  • FIGURE 12 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2022 & 2030 (USD BILLION)
  • FIGURE 13 GLOBAL AI IN DRUG DISCOVERY MARKET: BY REGION, 2022 & 2030 (USD BILLION)
  • FIGURE 14 GLOBAL AI IN DRUG DISCOVERY MARKET SHARE (%), BY REGION, 2022
  • FIGURE 15 NORTH AMERICA: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 16 EUROPE: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 17 ASIA-PACIFIC: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 18 REST OF THE WORLD: AI IN DRUG DISCOVERY MARKET SHARE (%), BY REGION, 2022
  • FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
  • FIGURE 21 GLOBAL AI IN DRUG DISCOVERY MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 22 IBM: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 23 IBM: SWOT ANALYSIS
  • FIGURE 24 ALPHABET INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 25 ALPHABET INC.: SWOT ANALYSIS
  • FIGURE 26 ATOMWISE INC.: SWOT ANALYSIS
  • FIGURE 27 MICROSOFT CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 MICROSOFT CORPORATION: SWOT ANALYSIS
  • FIGURE 29 BENEVOLENTAI: SWOT ANALYSIS
  • FIGURE 30 EXSCIENTIA: FINANCIAL OVERVIEW SNAPSHOT